FDA Clearance Tracker · K243561
Nano-Check Influenza+COVID-19 Dual Test
Last checked: Nov 20, 2026Latest source record: Jun 17, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jun 17, 2025
Substantially Equivalent
Time to decision
211 days
Received Nov 18, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Dual Track
Device class
Class II
The decision
- FDA number
- K243561
- Device name
- Nano-Check Influenza+COVID-19 Dual Test
- Applicant
- Nano-Ditech Corporation
- Applicant location
- Cranbury, NJ
- Received
- Nov 18, 2024
- Decided
- Jun 17, 2025
- Decision
- Substantially Equivalent
- Submission type
- Dual Track
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.3987
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code SCA. The earliest in FDA's data is DEN240029, decided Oct 7, 2024.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243561
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Nano-Ditech Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252283 · Decided Jan 15, 2026 · 177 days after receipt
Device type: Devices Detecting Influenza A, B, And C Virus Antigens (PSZ) · Laboratory Medicine & Pathology
- Nano-Check RSV Test510(k)
K240280 · Decided Jul 30, 2024 · 180 days after receipt
Device type: Antigen, Cf (Including Cf Controls), Respiratory Syncytial Virus (GQG) · Laboratory Medicine & Pathology
K231187 · Decided Jan 23, 2024 · 272 days after receipt
Device type: Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings (QVF) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.